Amedisys Inc  (AMED) Trade Now »     Rate AMED  -  Discuss AMED  -  Add to Watch List        

Growth to PE = 1.89 > undervalued

Price / Sales = 1.3 > reasonably valued

Sales growth 60% >growth in a bad economy

Earnings yield = 7.6% >pricing power intact

 AMED operates 261 Medicare-certified home health agencies and 14 Medicare-certified hospice agencies in 19 states.

So growth is high but with only 19 states covered it can reasonably grow @ 20% for 2-3 years. They are the fastest grower in their industry.  Potential buyout cnadidate.

"Amedisys (NASDAQ: AMED), one of the nation’s leading home health care companies, is a bear-proof stock," says David Fessler, a leading stock advisor and Oxford Club Advisory Panelist. 

He explains, "The stock is defying the market. It’s one of the best non-cyclical companies on the planet, which means it’s recession proof." here's his review.

" Amedisys has more than 8,000 caregivers, working from more than 350 home health centers and hospice agencies, across more than 30 states. These centers typically serve residents within a 50-mile radius.

"And it sure helps to operate within a lucrative

this afternoon and came across Amedisys (AMED) which is an old favorite of this blog. AMED is currently trading at $33.80, up $2.44 or 7.78% on the day. I do not own any shares of Amedisys nor do I have any options on this stock.

AMEDISYS (AMED) IS RATED A BUY

I say "old favorite" because I have posted twice about this stock previously. I first wrote up Amedisys on Stock Picks Bob's Advice on June 21, 2004 , when the stock was trading at $30.74. With the stock splitting 4:3 on December 5, 2006, th